Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
| Buyback Record Date | |
| Buyback Open Date | November 21, 2022 |
| Buyback Closing Date | May 3, 2023 |
| Issue Size (Amount) | ₹25.00 Crores |
| Buyback Price | ₹325 per Share |
Windlas Biotech Limited is coming up with BuyBack of the face value of ₹5 each, for an amount of ₹[.] Crores ('Base Issue Size') with an option to retain oversubscription up to ₹25.00 Crores.
Incorporated in 1991, Windlas Biotech Limited is in the business of providing pharmaceutical services. The company manufactures solid and liquid pharmaceutical dosage forms and provides a comprehensive range of services and specialized capabilities that include product discovery, product development, licensing, and commercial manufacturing of generic products.
The issue opens on Nov 21, 2022 and closes for subscription on May 20, 2023. The shares of the company to be list at BSE, NSE.
The public issue of Windlas Biotech Limited opens on Nov 21, 2022 and closes for subscription on May 20, 2023.
The Windlas Biotech Buyback 2022 are proposed to list at BSE, NSE.
This page provides Buyback news of Windlas Biotech Buyback 2022. The Windlas Biotech Buyback 2022 watch offers the latest Buyback issue news and keep you updated with the latest Buyback news in India.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
